10 results
8-K
EX-2
EBS
Emergent Biosolutions Inc
18 May 22
Entry into a Material Definitive Agreement
5:13pm
8-K
EX-2
EBS
Emergent Biosolutions Inc
15 Oct 18
Completion of Acquisition or Disposition of Assets
5:22pm
8-K
EX-2.1
EBS
Emergent Biosolutions Inc
5 Oct 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-2
EBS
Emergent Biosolutions Inc
3 Oct 17
Emergent Biosolutions Completes Acquisition of Raxibacumab, an Fda-approved Anthrax Monoclonal Antibody, from GSK
12:00am
8-K
EX-2
EBS
Emergent Biosolutions Inc
14 Jul 17
Emergent Biosolutions to Acquire ACAM2000® Business from Sanofi
12:00am
8-K
EX-2.2
88jsakebzh kl06kya
4 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2
fwgwb8hps
4 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2
40m4f3v8 ylboe075nt6
12 Dec 13
Emergent Biosolutions to Acquire Cangene Corporation
12:00am
8-K
EX-2.1
as7qfjxc
13 Aug 10
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
bp7a3
13 Aug 10
Business combination disclosure
12:00am
- Prev
- 1
- Next